MOESM3 of The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort
收藏数据链接：
官方服务：
资源简介：
Additional file 3: Table S3. Histological subtype, clinical outcome (response to anti-PD1 and survival), TIS score and normalized gene expression data, for each of the 58 samples included in the study.
创建时间：
2019-11-05
